Fact CheckerSign in

NCT07496853Recruiting

Effect of Upper Extremity Support on Spatiotemporal Parameters of Gait in Individuals With Stroke

The Effect of Upper Extremity Support Usage on Spatiotemporal Gait Parameters in Individuals With Stroke: A Prospective Cross-over Experimental Study

Source: ClinicalTrials.gov · Last updated 27 Mar 2026

Brief summary (registry, in English)

Purpose: The primary goal of this study is to investigate how different levels of upper extremity (arm) support affect walking patterns in individuals who have experienced a stroke. Specifically, the research aims to determine how restricting or facilitating arm swing during walking modulates spatiotemporal gait parameters (such as speed, step length, and rhythm). Background: Arm swing plays a crucial role in maintaining balance, stability, and energy efficiency during normal walking. Following a stroke, many patients use walking aids (like canes or walkers) or clinical supports (like parallel bars) that restrict natural arm movement. This study examines whether these restrictions significantly alter gait mechanics in the stroke population. Methodology: Participants will participate in a cross-over experimental trial. Each participant will walk on a specialized treadmill system (C-Mill VR+) under three randomized conditions: 1. Unsupported walking (no arm support), 2. Single-arm support (using the non-paretic side), 3. Dual-arm support (using both arms). Researchers will record gait speed, step length, cadence, and duration of stance/swing phases for each condition. Expected Outcome: The findings will provide scientific evidence on how different support strategies modulate walking performance. This information will help physical therapists design more effective, individualized rehabilitation programs to improve mobility and quality of life for stroke survivors.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
34 (estimated)
First submitted
11 Mar 2026
Start date
1 Apr 2026
Primary completion date
15 Dec 2026
Lead sponsor
Ankara Yildirim Beyazıt University
Diseases
Stroke
NCT number
NCT07496853

What you commit to

  • Study type: Interventional
  • Planned participants: 34
  • From 1 Apr 2026 to the primary completion date, 15 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Recurrent stroke.

Other

  • Presence of aphasia.
  • Montreal Cognitive Assessment (MoCA) score below 10 points.

Who the study is looking for

  • Diagnosis of hemiplegia with ICD-10 code G.81.
  • Presence of unilateral hemiplegia.
  • No medical contraindications for the use of assistive devices (e.g., cane, tripod).
  • Aged 18 years or older.
  • Ability to walk for at least 2 consecutive minutes.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ankara Bilkent City Hospital
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.